Upload Avatar (500 x 500)
Xiaoyan Qiu
Chinese, English
Beijing
Peking University
Basic Medical Sciences
  • 1982 - Bachelor of Medicine from Heilongjiang University of Chinese Medicine
  • 1988 - Master of Medical Pathology from Norman Bethune Medical University
  • 1996 - PhD in Immunology from Norman Bethune Medical University
  • 1982-12 - 1985-08 - Resident Physician, Pathology Department, Heilongjiang University of Chinese Medicine Hospital
  • 1988-09 - 1992-08 - Attending Physician, Pathology Department, Heilongjiang University of Chinese Medicine Hospital
  • 1996-11 - 1998-11 - Postdoctoral Research, Academy of Military Medical Sciences
  • 1998-12 - Present - Associate Professor, Professor, Peking University, School of Basic Medical Sciences, Department of Immunology
  • 1992 - Second Prize, Science and Technology Progress, Heilongjiang Province
  • 1999 - First Prize, Science and Technology Progress by Traditional Chinese Medicine Management Bureau of Heilongjiang Province
  • 2000 - Third Prize, Science and Technology Progress, Heilongjiang Province
  • 2003 - Second Prize, SCI Papers, Peking University Medical Department
  • 2004 - Second Prize, Science and Technology Progress, Ministry of Education
  • 2008 - Second and Third Prize, Excellent SCI Papers, Peking University School of Basic Medical Sciences
  • 2009 - Second Prize, Excellent SCI Papers, Peking University School of Basic Medical Sciences
  • 2010 - Second Prize, Excellent SCI Papers, Peking University School of Basic Medical Sciences
  • 2011 - Patent Invention Award, Peking University Medical Department
  • 2012 - Patent Invention Award, Peking University Medical Department
  • 2012 - First Prize, Excellent SCI Papers, Peking University School of Basic Medical Sciences
  • 2013 - First Prize, Excellent SCI Papers, Peking University School of Basic Medical Sciences
  • 2014 - Excellent SCI Papers Award, Peking University School of Basic Medical Sciences
Tumor Immunology
Significance of tumor cell expressed Ig in tumor development
Tumor immune microenvironment research
Immunological mechanisms of inflammation to cancer transformation
Tumor immunotherapy research
  • Binding of the monoclonal antibody RP215 to immunoglobulin G in metastatic lung adenocarcinomas is correlated with poor prognosis, Xiaoyan Qiu, 2015
  • Contribution of CCDC134, a Potential Cytokine, to CD8+ T Cell Effector Functions in Cancer Immunotherapy, Xiaoyan Qiu, 2014
  • IgG and IgA with Potential Microbial-binding Activity are Expressed by Normal Human Skin Epidermal Cells, Xiaoyan Qiu, 2014
  • The immunoglobulin heavy chain VH6-1 promoter regulates Ig transcription in non-B cells, Xiaoyan Qiu, 2014
  • Rearrangement and expression of the immunoglobulin μ-chain gene in human myeloid cells, Xiaoyan Qiu, 2014
  • Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis, Xiaoyan Qiu, 2013
  • Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia, Xiaoyan Qiu, 2012
  • Rearrangement and expression of immunoglobulin μ chain gene in human myeloid cells, Xiaoyan Qiu, 2012
  • Spontaneous Production of Immunoglobulin M in Human Epithelial Cancer Cells, Xiaoyan Qiu, 2012
  • CCDC134 interacts with hADA2a and functions as a regulator of hADA2a in acetyltransferase activity, DNA damage-induced apoptosis and cell cycle arrest, Xiaoyan Qiu, 2012
  • The Role of Human ADA2a in the Regulation of p53 Acetylation and Stability, Xiaoyan Qiu, 2010
  • Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells, Xiaoyan Qiu, 2010
  • Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands, Xiaoyan Qiu, 2010
Tumor Immunology Ig Expression Tumor Development Immune Microenvironment Inflammation Cancer Transformation Immunotherapy Research Cell Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.